INNER EAR FLUIDS

A Comprehensive 20-Mark Answer (RGUHS Standard)

OVERVIEW AND INTRODUCTION

"The bony channels are filled with perilymph, which surrounds the membranous canals. Perilymph is essentially a typical extracellular fluid, similar, but not identical, to cerebrospinal fluid (CSF) or serum." — Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol. 2, Ch. 47 (Gale & Forge)

1. ANATOMICAL COMPARTMENTS

BONY LABYRINTH
├── Scala Vestibuli ──────────────── PERILYMPH (High Na+, Low K+)
│        │ (communicates via helicotrema)
├── Scala Tympani  ──────────────── PERILYMPH (High Na+, Low K+)
│
MEMBRANOUS LABYRINTH
├── Scala Media (Cochlear Duct) ─── ENDOLYMPH (High K+, Low Na+, +80 mV EP)
├── Saccule  ────────────────────── ENDOLYMPH
├── Utricle  ────────────────────── ENDOLYMPH
├── Semicircular Canal Ducts ─────── ENDOLYMPH
└── Endolymphatic Duct & Sac ─────── Resorption of Endolymph

• Reissner's membrane (roof) - superiorly
• Basilar membrane (floor) - inferiorly

2. IONIC COMPOSITION

Table: Comparison of Inner Ear Fluids

Key points:

• Endolymph is the only extracellular fluid with high K⁺ and low Na⁺ (resembles intracellular fluid)
• The very low Ca²⁺ in endolymph is critical for tip-link integrity in stereocilia
• The +80 mV endocochlear potential (EP) is unique to cochlear endolymph; vestibular endolymph has ~0 mV

3. PERILYMPH

A. Definition and Origin

B. Sources of Perilymph (Flowchart)

                    SOURCES OF PERILYMPH
                           │
          ┌────────────────┼─────────────────┐
          ▼                ▼                 ▼
   Blood plasma      CSF via          Local secretion by
   (ultrafiltration  cochlear          fibrocytes of
   via vessels)      aqueduct          spiral ligament
          │                │                 │
          └────────────────┴─────────────────┘
                           │
                    PERILYMPH (High Na+, Low K+)
                           │
                    Fills scala vestibuli
                    and scala tympani

• Primary source: Ultrafiltration from blood vessels in the spiral ligament and cochlear capsule
• Secondary source: Possible contribution from CSF via the cochlear aqueduct (however, the exact compositions differ, indicating local modification)
• The cochlear aqueduct connects the scala tympani perilymph with the subarachnoid space; this is why meningitis can affect the inner ear

"The perilymphatic compartment connects with the arachnoid space of the brain via the cochlear aqueduct... indicating that perilymph is produced or at least significantly modified locally in the inner ear." — Scott-Brown's, Vol. 2, Ch. 47

C. Drainage of Perilymph

• Via cochlear aqueduct to CSF
• Possible absorption by fibrocytes of the spiral ligament

4. ENDOLYMPH

A. Definition and Unique Properties

B. Production of Endolymph

        ENDOLYMPH PRODUCTION
               │
    ┌──────────┴──────────┐
    ▼                     ▼
COCHLEAR ENDOLYMPH    VESTIBULAR ENDOLYMPH
(Scala media)          (Utricle/Saccule/SCC)
    │                     │
    ▼                     ▼
STRIA VASCULARIS      DARK CELLS of vestibular
(primary secretory     epithelium (utricle/SCC
organ for K+)          ampullae)

Stria Vascularis - The Engine of Endolymph Production

STRIA VASCULARIS LAYERS:
┌─────────────────────────────────────────────┐
│  MARGINAL CELLS  ← face Scala Media        │
│  (secrete K+ into endolymph via KCNQ1/KCNE1)│
├─────────────────────────────────────────────┤
│  INTRASTRIAL COMPARTMENT                    │
│  (fluid: +100 mV, low K+)                  │
│  + Intermediate cells (KCNJ10 channel)      │
│  + Blood vessels                            │
├─────────────────────────────────────────────┤
│  BASAL CELLS  ← face Perilymph/Spiral lig. │
│  (tight junctions + gap junctions)          │
└─────────────────────────────────────────────┘

"The stria vascularis plays a pivotal role in cochlear homeostasis by generating the endocochlear potential and maintaining the unique ion composition of the endolymph." — Shambaugh Surgery of the Ear, p. 102

C. Absorption/Drainage of Endolymph

ENDOLYMPH DRAINAGE / RESORPTION
          │
    ┌─────┴──────┐
    ▼            ▼
ENDOLYMPHATIC   REISSNER'S MEMBRANE
SAC             (minor role - bidirectional
(primary site    transport of ions & water)
of resorption)
    │
    ▼
Endolymphatic duct → Endolymphatic sac
(projects into posterior cranial fossa,
under the dura)
    │
    ▼
Resorption of ions, fluid, and immune
surveillance of endolymph

• Rugose (proximal) portion: heavily folded, with large phagocytic cells - active resorption
• Smooth (distal) portion: less folded, immunologically active

5. THE ENDOCOCHLEAR POTENTIAL (EP) AND K⁺ RECYCLING

The Endocochlear Potential

"Hearing threshold increases approximately 1 dB per mV loss of endocochlear potential." — Shambaugh Surgery of the Ear, p. 103

The K⁺ Recycling Pathway (The "Potassium Cycling Model")

Fig. 148.20 from Cummings Otolaryngology - Proposed scheme for K⁺ circulation in the cochlea

Figure 4-7 from Shambaugh Surgery of the Ear - K⁺ flow pathway with molecular detail

K+ RECYCLING FLOWCHART (Potassium Cycling Model)

ENDOLYMPH (Scala media, +80 mV, [K+] = 157 mM)
        │
        │ K+ enters hair cell via
        │ MET channels at stereocilia tips
        ▼
HAIR CELL (depolarization)
        │
        │ K+ exits basolateral membrane
        │ via KCNQ4 channels
        ▼
PERILYMPH (Scala tympani)
        │
    ┌───┴───────────────────────┐
    ▼                           ▼
PATHWAY A:                  PATHWAY B:
Perilymphatic space         Epithelial gap junction network:
(minor)                     Deiters' cells → Hensen's cells →
                            Claudius cells → Root cells
                                   │
                            KCC3/KCC4 cotransporters take up K+
                                   │
                                   ▼
                           SPIRAL LIGAMENT fibrocytes
                           (Type II fibrocytes take up K+
                           via Na/K-ATPase and NKCC1)
                                   │
                           Connective tissue gap junction
                           network (Cx26, Cx30, Cx31, Cx43)
                                   │
                                   ▼
                    STRIA VASCULARIS (Basal → Intermediate cells)
                           │
                    INTERMEDIATE CELLS
                    (KCNJ10 releases K+ into intrastrial space)
                           │
                           ▼
                    INTRASTRIAL SPACE (+100 mV, low K+)
                           │
                    MARGINAL CELLS take up K+ via:
                    • NKCC1 (Na+/K+/2Cl- cotransporter)
                    • Na+/K+-ATPase (ATP1A1, ATP1B1, ATP1B2)
                           │
                           ▼
                    K+ secreted into SCALA MEDIA
                    via KCNQ1/KCNE1 channels
                    (apical surface of marginal cells)
                           │
                           ▼
                    ENDOLYMPH [K+] maintained at 157 mM
                    Endocochlear potential = +80 mV

"K+ is efficiently removed from the intrastrial space by marginal cells, which actively take up K+ via NKCC1 (Na+/K+/2Cl−) cotransporters and by Na+/K+-ATPases. Finally, marginal cells secrete K+ into the scala media via the KCNQ1/KCNE1 K+ channel." — Shambaugh Surgery of the Ear, p. 103

6. ION TRANSPORTERS AND CHANNELS - SUMMARY TABLE

"Homeostatic mechanisms that involve the maintenance of separate endolymphatic and perilymphatic compartments... are essential for normal auditory function. Numerous mutant genes that alter homeostasis and are responsible for hereditary hearing impairments have been identified." — Cummings Otolaryngology 7th Ed., Fig. 148.19-148.20

7. GENETIC DISORDERS OF INNER EAR FLUID HOMEOSTASIS

8. ENDOLYMPH VOLUME REGULATION AND FLOW

Two Historical Theories:

1. Longitudinal flow theory: Endolymph flows from the cochlear duct apically and drains into the endolymphatic sac. Favored historically.
2. Radial flow theory: Local production and absorption balanced radially.

Current Understanding:

"Today, the prevailing thought is that there is no significant volume flow under physiological conditions. Experiments in animals have shown that markers iontophoresed into the endolymph without volume disturbance move solely by diffusion. The ions in the endolymph, therefore, turn over locally without concomitant volume flow." — Shambaugh Surgery of the Ear, p. 103

Role of Aquaporins in Volume Regulation:

WATER TRANSPORT IN INNER EAR

Vasopressin (ADH)
       │
       ▼
   AQP2 in endolymphatic sac
   (membrane expression increases)
       │
       ▼
   Increased water resorption
   from endolymph → normal volume
       │
   (If vasopressin pathologically elevated)
       ▼
   Excessive water retention → ENDOLYMPHATIC HYDROPS
   (morphological basis of Ménière's disease)

• AQP2: In endolymphatic sac, regulated by vasopressin (AVP) - key for volume regulation
• AQP4: In perilymphatic tissues; knockout mice show hearing impairment
• AQP10, AQP11, AQP12: Recently identified in rat stria vascularis (Ichikawa et al., Acta Otolaryngol 2024, PMID 38511591)

9. VESTIBULAR ENDOLYMPH vs. COCHLEAR ENDOLYMPH

10. THE ENDOLYMPHATIC SAC - STRUCTURE AND FUNCTION

ENDOLYMPHATIC SAC FUNCTIONS
          │
   ┌──────┼──────┬──────────┐
   ▼      ▼      ▼          ▼
FLUID   ION    IMMUNE    PRESSURE
RESORB- REGUL- SURVEIL-  SENSOR
TION    ATION  LANCE
│       │      │          │
AQP2   Na+ /  IgA, IgG   Responds to
Cl-    H+     phagocytic  changes in
transport exchange cells    endolymph
               present     volume

• Destruction/dysfunction of ELS → endolymphatic hydrops → Ménière's disease
• ELS contains IgA secreting cells and macrophages (immune role)
• Surgical decompression/shunting of ELS is a treatment for intractable Ménière's disease

11. CLINICAL RELEVANCE - FLOWCHART

INNER EAR FLUID DISTURBANCES
          │
    ┌─────┴──────┐
    ▼            ▼
ENDOLYMPH      PERILYMPH
DISTURBANCE    DISTURBANCE
    │                │
    ▼                ▼
ENDOLYMPHATIC    PERILYMPH
HYDROPS          FISTULA
    │                │
    ▼                ▼
Ménière's disease  Trauma / barotrauma
(Fluctuating SNHL, • Oval/round window
vertigo, tinnitus,   fistula
aural fullness)    • Fluctuating SNHL
    │              • Perilymph behind
    ▼                TM (sign)
Treatment:
• Diuretics (↓ endolymph)
• Salt restriction
• Betahistine
• ELS surgery
• Intratympanic dexamethasone/
  gentamicin

12. REISSNER'S MEMBRANE

• A thin two-layered membrane separating scala vestibuli (perilymph) from scala media (endolymph)
• Inner layer: Simple squamous epithelium (faces endolymph) - contains Na⁺/K⁺-ATPase, ion channels
• Outer layer: Mesothelial cells (faces perilymph)
• Functions:
  • Maintains the electrolyte barrier between endolymph and perilymph
  • Active ion transport (Na⁺ and Cl⁻ from endolymph to perilymph)
  • Contributes to endolymph volume regulation

13. RECENT ADVANCES (2021-2026)

1. Aquaporin Subtypes in Stria Vascularis

2. Endolymph Proteomics

3. Vasopressin-AQP2 Axis in Ménière's Disease

4. Cell and Gene Therapy for Inner Ear Fluid Disorders

5. Potassium Channel Pharmacology

SUMMARY DIAGRAM

INNER EAR FLUID COMPARTMENTS - COMPLETE OVERVIEW

                    ┌─────────────────────────────────────┐
                    │         MEMBRANOUS LABYRINTH        │
                    │                                     │
   BONY LABYRINTH   │  ┌─────────────────────────────┐   │
   (Perilymph)      │  │      ENDOLYMPH               │   │
   High Na+, Low K+ │  │  High K+ (157 mM)            │   │
   ~0 mV            │  │  Low Na+ (1.3 mM)            │   │
                    │  │  Low Ca²+ (0.023 mM)         │   │
   Source:          │  │  +80 mV (EP)                 │   │
   • Blood          │  │                              │   │
     ultrafiltrate  │  │  Source:                     │   │
   • CSF via        │  │  • Stria vascularis          │   │
     cochlear       │  │    (cochlea)                 │   │
     aqueduct       │  │  • Dark cells (vestibule)    │   │
   • Spiral         │  │                              │   │
     ligament       │  │  Drainage:                   │   │
                    │  │  • Endolymphatic sac          │   │
   Drainage:        │  │    (main)                    │   │
   • Cochlear       │  │  • Reissner's membrane       │   │
     aqueduct       │  │    (minor)                   │   │
   • Fibrocytes     │  └─────────────────────────────┘   │
                    └─────────────────────────────────────┘

   KEY BARRIER: Tight junctions of epithelial cells lining membranous labyrinth
   KEY GENERATOR: Stria vascularis (KCNJ10 + KCNQ1/KCNE1 + Na/K-ATPase + NKCC1)
   KEY RECYCLER: Gap junction networks (Connexins 26, 30, 31, 43)
   KEY REGULATOR: Endolymphatic sac (AQP2 + vasopressin axis)

REFERENCES (RGUHS Preferred Sources)

QUICK REVISION POINTS (RGUHS 20-Mark Checklist)

1. Two compartments: Perilymph (bony labyrinth) and Endolymph (membranous labyrinth)
2. Perilymph: High Na⁺ (148 mM), Low K⁺ (4.2 mM) - like ECF/CSF
3. Endolymph: High K⁺ (157 mM), Low Na⁺ (1.3 mM), very Low Ca²⁺ (0.023 mM) - like ICF
4. Endocochlear potential: +80 mV (cochlea only, not vestibule)
5. Generated by: Stria vascularis (marginal cells via KCNQ1/KCNE1)
6. K⁺ recycling via: Gap junctions (Connexins 26, 30, 31, 43) through supporting cells → spiral ligament → stria vascularis
7. KCNJ10 in intermediate cells - essential for EP generation
8. Endolymph drainage via endolymphatic sac (main) + Reissner's membrane (minor)
9. Perilymph source: blood ultrafiltrate + CSF via cochlear aqueduct
10. Water regulation: Aquaporin 2 (vasopressin-regulated) in endolymphatic sac
11. GJB2 mutations (Connexin 26) = most common cause of hereditary SNHL (DFNB1)
12. Endolymphatic hydrops → Ménière's disease; excess AVP → AQP2 overactivation
13. Perilymph fistula: leak of perilymph through oval/round window → fluctuating SNHL
14. Furosemide inhibits NKCC1 → reduces EP → used to test cochlear function (electrocochleography)
15. Pendrin (SLC26A4) - Cl⁻/HCO₃⁻ exchanger in ELS - mutations cause Pendred syndrome + EVA